Open Access
SARS‐CoV2 disease seen through the prism of acutely decompensated chronic kidney disease and ischemic stroke: What lesson we have learned from using prophylaxis therapy of vascular thromboembolism?
Author(s) -
Hazim Asmaa,
Aasfara Jehanne,
Slassi Ilham,
Canaud Bernard,
Haoudar Amal,
Naitlhou Abdelhamid,
El Kettani Chafik
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3385
Subject(s) - medicine , stroke (engine) , antithrombotic , kidney disease , context (archaeology) , intensive care medicine , disease , cardiology , mechanical engineering , paleontology , engineering , biology
Abstract Our case underlines the tight management of antithrombotic therapy in the context of acutely decompensated chronic kidney disease, ischemic stroke, and SARS‐CoV2 infection, the development of stroke as a SARS‐CoV2 complication increase the chances of adverse outcomes that may be mitigated by a rapid recognition and institution of available treatments.